FT : Tree-planting and land pledges would need area bigger than US, report estim

Tree-planting and land pledges would need area bigger than US, report estimates
Countries have promised 1.2bn hectares in total of new forests and restored land to help curb climate change

Climate pledges made by countries worldwide are “dangerously overreliant” on tree planting and land restoration that would require an area greater than the size of the US and risked sparking conflict, a study has concluded.

The assessment of the national climate plans submitted by nearly 200 nations to the UN found they would require a total of 1.2bn hectares of land for nature-based carbon removal activities, such as tree planting.

The strategy was not only slow to implement but could create conflict by displacing farmland and putting climate and food security objectives at odds, said the report, compiled by more than 20 researchers led by the University of Melbourne’s Climate Futures initiative.

Countries were turning to land-based solutions instead of doing “the hard work of steeply reducing emissions from fossil fuels, decarbonising food systems and stopping the destruction of forests and other ecosystems”, said Kate Dooley, the lead author.

“Faced with a global land squeeze, we must think carefully about how we use each and every plot of land,” she added, in a report that comes just days before the UN COP27 climate summit in Egypt, where food and land use is on the agenda.

Global land area, excluding ice and barren rock, is estimated at 13bn hectares.

The report concluded that 166 countries plus the EU bloc had stated intentions to plant trees on 633mn hectares, including single-species plantations, which would drive up competition for the space with industries such as agriculture. Many nations had issued targets for their own land, but in some cases the commitments were vague.

Another 551mn hectares of degraded land would be restored, a practice that “holds more promise for climate and biodiversity and poses fewer threats to other dimensions of sustainability”, researchers said.

Recommended

The Big Read
The ancient subarctic forests at risk from climate change and war

Reforestation has become popular among governments, companies and investors looking for ways to offset their carbon dioxide emissions. Many carbon offsets, which are used by buyers to compensate for pollution, are generated by unregulated tree-planting schemes.

Last week, the UN said many countries were planning to use a new carbon credit system, the rules of which were finalised at last year’s COP26 meeting, to help meet their national decarbonisation goals.

The researchers said cutting emissions as quickly as possible, including making food systems more sustainable, was required, rather than relying on longer processes for carbon removal.

Newly planted trees take years to absorb significant quantities of carbon and would not achieve the reductions needed by 2030 to curb global warming, they said.

A separate study reported that the global deforestation rate fell 6.3 per cent in 2021 compared with the 2018-20 period, largely thanks to progress made by Indonesia and Malaysia.

But the report from Forest Declaration Assessment, an independent, civil society-led initiative, said the rate remained too slow to meet the UN pledge to halt deforestation by 2030, which requires a drop of around 10 per cent annually.

“Multiple streams of data show that the world is not on track to achieve our commitments to protect forests. We are quickly moving toward another round of hollow commitments and vanished forests,” said David Gibbs, a forests researcher at the World

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • VRNS -33.3% (also authorizes new $100 mln share repurchase program), CTLT -13.2%, PBI -12.5%, GT -7.9%, TREX -7.1%, FLS -6.6%, SYK -6.2%, ZBRA -6.1%, RGEN -4.7%, PINC -4%, CLW -3.4%, AXNX -3.3%, HLIT -2.9%, ETRN -2.6%, ARNC -2.5%, LLY -2.1%, RHP -1.4%, LGIH -1.2%, TAP -0.9%

Other news:

  • SSL -5.4% (launches offering of $750 mln guaranteed senior unsecured convertible bonds due 2027)
  • NUVL -1.1% (prices offering of 6865672 shares of Class A common stock at $33.50 per share)
  • JNJ -0.7% (Johnson & Johnson to acquire Abiomed (AMBD) for $380/share in cash; expected to be accretive to adj. earnings beginning in 2024)

Analyst comments:

  • SYK -5.3% (downgraded to Hold from Buy at Canaccord Genuity)
  • CLW -3.4% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
  • TIL -1.8% (downgraded to Market Perform from Outperform at Cowen)
  • UNP -0.6% (downgraded to Underperform from Sector Perform at RBC Capital Mkts)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • SOFI +12.9%, UBER +9.6%, BCOR +8.9%, HOLX +8.4%, BSM +6%, AMKR +5%, ECVT +4.9%, PFE +4.7%, LSCC +4.5%, PLOW +4.1%, LEG +3.7%, CIVI +3.7%, WAT +3.6%, CAR +3.5%, ADUS +3.5%, ICPT +3.1%, SONY +3%, PACK +2.9%, IMAX +2.8%, MPLX +2.7%, STNG +2.7%, HSC +2.1%, ARCB +2%, VAL +1.6%, IDXX +1.6%, INCY +1.6%, MPC +1.5%, XYL +1.5%, NXPI +1.4%, WEC +1.3%, SIRI +1.3%, CINF +1.1%, LPX +1.1%

Other news:

  • ABMD +51.7% (Johnson & Johnson to acquire Abiomed (AMBD) for $380/share in cash; expected to be accretive to adj. earnings beginning in 2024)
  • LI +9.2% (October deliveries)
  • NIO +7.1% (October deliveries)
  • MLCO +7.1% (following Macau Gaming revs for October)
  • XPEV +5.4% (October deliveries)
  • LVS +4.7% (following Macau Gaming revs for October)
  • RRGB +4.5% (CFO to retire)
  • BZUN +4.3% (announces primary listing on the Main Board of The Stock Exchange of Hong Kong effective today)
  • GME +3.7% (GameStop's NFT Marketplace launches with ImmutableX)
  • ATCO +3.4% (to be acquired by Poseidon Acquisition Corp. for $15.50 in cash per share)
  • IMO +3% (announces terms of its substantial issuer bid for up to $1.5 bln and receipt of exemptive relief)
  • DEN +2.8% (executes CO2 Services Agreement with Clean Hydrogen Works)
  • WYNN +2.8% (following Macau Gaming revs for October)
  • KPTI +2.1% (EC grants orphan designation for selinexor for myelofibrosis)
  • MGM +2% (following Macau Gaming revs for October)
  • AZN +1.8% (reports Vaxzevria receives full Marketing Authorisation in the EU for the prevention of COVID-19)
  • NVTA +1.6% (study shows therapy informed by genetic testing reduces seizures in some patients with epilepsy)

Analyst comments:

  • FSLR +3% (upgraded to Equal Weight from Underweight at Barclays)
  • NSC +3% (upgraded to Sector Perform from Underperform at RBC Capital Mkts)
  • MNST +2.3% (upgraded to Overweight from Neutral at JP Morgan)
  • LPLA +1.8% (upgraded to Outperform from Neutral at Credit Suisse)

>>> US Research Calls

Research Calls

  • Upgrades:
    • AnaptysBio (ANAB) upgraded to Buy from Neutral at Guggenheim; tgt $44
    • Auto Trader (ATDRY) upgraded to Buy from Neutral at UBS
    • Carvana (CVNA) upgraded to Neutral from Underweight at JP Morgan; tgt $20
    • Exxon Mobil (XOM) upgraded to Neutral from Underperform at Exane BNP Paribas; tgt $115
    • First Solar (FSLR) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $162
    • Gogo (GOGO) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $15
    • Komatsu (KMTUY) upgraded to Neutral from Sell at Goldman
    • Lennox Int'l (LII) upgraded to Neutral from Underweight at JP Morgan; tgt $226
    • LPL Financial (LPLA) upgraded to Outperform from Neutral at Credit Suisse; tgt $315
    • Monster Beverage (MNST) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $106
    • Norfolk Southern (NSC) upgraded to Sector Perform from Underperform at RBC Capital Mkts; tgt raised to $237
  • Downgrades:
    • Altra Industrial Motion (AIMC) downgraded to Neutral from Outperform at Robert W. Baird; tgt $62
    • Banco Santander Brasil (BSBR) downgraded to Underperform from Neutral at BofA Securities
    • Centerspace (CSR) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $70
    • Charles Schwab (SCHW) downgraded to Neutral from Outperform at Credit Suisse; tgt $84
    • Clearwater Paper (CLW) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt $45
    • Emerson (EMR) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $96
    • Guardant Health (GH) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $50
    • Instil Bio (TIL) downgraded to Market Perform from Outperform at Cowen
    • Principal Fincl (PFG) downgraded to Equal Weight from Overweight at Barclays; tgt raised to $89
    • RPT Realty (RPT) downgraded to Neutral from Outperform at Credit Suisse; tgt $10
    • Stryker (SYK) downgraded to Hold from Buy at Canaccord Genuity; tgt lowered to $220
    • Steven Madden (SHOO) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $29
    • TuSimple Holdings (TSP) downgraded to Perform from Outperform at Oppenheimer
    • TuSimple Holdings (TSP) downgraded to Underweight from Overweight at JP Morgan
    • Union Pacific (UNP) downgraded to Underperform from Sector Perform at RBC Capital Mkts; tgt lowered to $187
    • Varonis Systems (VRNS) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $20
    • Varonis Systems (VRNS) downgraded to Underweight from Overweight at Wells Fargo; tgt lowered to $24
    • Varonis Systems (VRNS) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $20
  • Others:
    • ACADIA Pharmaceuticals (ACAD) initiated with a Hold at Loop Capital; tgt $17
    • atai Life Sciences N.V. (ATAI) initiated with a Buy at Loop Capital; tgt $18
    • ATS Automation (ATSAF) assumed with an Outperform at RBC Capital Mkts
    • Axsome Therapeutics (AXSM) initiated with a Buy at Loop Capital; tgt $95
    • Cerevel Therapeutics (CERE) initiated with a Buy at Loop Capital; tgt $40
    • Chemours (CC) initiated with an Underperform at Credit Suisse; tgt $24
    • COMPASS Pathways (CMPS) initiated with a Buy at Loop Capital; tgt $34
    • Deckers Outdoor (DECK) resumed with a Buy at BofA Securities; tgt $425
    • EDAP TMS SA (EDAP) initiated with a Buy at Jefferies; tgt $11
    • Exelixis (EXEL) initiated with a Buy at EF Hutton; tgt $28
    • Evolent Health (EVH) initiated with a Hold at Truist; tgt $33
    • Horizon Pharma (HZNP) initiated with a Neutral at H.C. Wainwright; tgt $74
    • Intellia Therapeutics (NTLA) initiated with a Buy at EF Hutton; tgt $130
    • Karuna Therapeutics (KRTX) initiated with a Buy at Loop Capital; tgt $288
    • Kone Oyj (KNYJY) initiated with a Hold at Deutsche Bank
    • Legend Biotech (LEGN) initiated with an Outperform at Cowen
    • NorthWestern (NWE) initiated with a Neutral at JP Morgan; tgt $55
    • OptimizeRx (OPRX) initiated with a Buy at Stifel; tgt $19
    • PDS Biotechnology (PDSB) initiated with a Buy at B. Riley Securities; tgt $10
    • Regeneron Pharma (REGN) initiated with a Buy at EF Hutton; tgt $851
    • Rocket Pharmaceuticals (RCKT) initiated with a Buy at BTIG Research; tgt $35
    • SAGE Therapeutics (SAGE) initiated with a Hold at Loop Capital; tgt $41
    • Schindler (SHLAF) initiated with a Buy at Deutsche Bank
    • Sumitomo Mitsui (SMFG) resumed with a Buy at Nomura
    • Tronox (TROX) initiated with an Underperform at Credit Suisse; tgt $10
    • Under Armour (UAA) resumed with a Neutral at BofA Securities; tgt $8

FT : UK house prices fall in October as borrowing costs rise

UK house prices fall in October as borrowing costs rise
Market upheaval following mini-Budget hits property sector as household finances are squeezed

House prices fell last month for the first time in more than a year as the market upheaval sparked by the UK government’s “mini” Budget drove up borrowing costs and hit household finances.

Building society Nationwide on Tuesday said that house prices fell 0.9 per cent between September and October. That is the first such drop since July 2021, when a cut to stamp duty was being phased out, and the largest fall since June 2020 at the height of the coronavirus pandemic.

Annual growth in house prices slowed from 9.5 per cent to 7.2 per cent.

The figures confirm the effect the ill-fated “mini” Budget of September 23 had on a market that was already slowing in the face of rising global interest rates.

Data published on Monday by the Bank of England showed mortgage lending had been relatively resilient in the run-up to the fiscal statement, possibly because homebuyers were rushing to lock in offers they could afford in the expectation that borrowing costs would soon rise further.

Robert Gardner, Nationwide’s chief economist, said the sharp rise in market interest rates following the “mini” Budget — with some lenders quoting fixed rate mortgages above 6 per cent — had “added to stretched affordability at a time when household finances are already under pressure”.

Although mortgage rates appear to have peaked, they are likely to remain much higher than in the recent past, with investors betting that the BoE will raise the base rate from 2.25 per cent to 3 per cent on Thursday.

Gardner said a typical first-time buyer with a 20 per cent deposit would now face monthly mortgage payments worth 45 per cent of their take-home pay, based on an average mortgage rate of 5.5 per cent. That is a similar ratio to the one seen before the 2008 financial crisis.

He added that a “relatively soft landing” was still possible, if investor sentiment recovered and market interest rates continued to ease. Even though the economy was weakening, prices would be supported by low unemployment and the fact that many households would not have to pay higher mortgage rates until fixed-rate deals expired, he said.

But Samuel Tombs, economist at the consultancy Pantheon Macroeconomics, said the figures gave “the strongest signal yet that house prices will buckle”.

He added that pressures on household incomes were “set to intensify” as the government introduced tax rises to help fill a £50bn fiscal hole, while lenders would probably increase their spreads to reflect growing risks of homebuyers failing to keep up repayments.

Tombs and other analysts predicted house prices would fall by close to 10 per cent over the coming year, wiping out much of their gains since the onset of the pandemic.

Matthew Pointon, property economist at the consultancy Capital Economics, said: “Hopes that mortgage rates will fall back significantly and quickly are misplaced.”

He added that although quoted rates were falling back from earlier peaks, they would probably remain well above 5 per cent next year and drop to 4 per cent only in 2025 — a level that would “crush demand” by pricing many buyers out of the market.

FT : Opec head: ‘Mixed messages’ are holding back energy investment

Opec head: ‘Mixed messages’ are holding back energy investment
Plus, the power of superhot rock energy

Amid a global energy crisis, a policy paradox is emerging, whereby western governments call for Opec and other oil and gas producers to raise output while also saying they want to transition away from the same fossil fuels and restrict investment in more supply. Mike Wirth, Chevron’s chief executive, took aim at this contradictory message in his interview with me a couple of weeks ago.

Opec is on the front line of this policy dispute. Its decision last month to cut supply drew a huge backlash from the White House, which considered the decision to be political. Yet, since then, the US government has itself announced a plan to buy oil to replenish its emergency stockpile at a price designed to give producers “confidence to invest” (the same producers president Joe Biden yesterday threatened with more tax unless they upped supply). This is almost identical to the reason Opec offered for its decision to cut output.

Haitham Al Ghais, Opec’s secretary-general, writes exclusively for us today, giving his view of these “mixed messages”. After the controversy of the last meeting and just days ahead of the UN climate conference in Egypt, it’s a must-read.

And see below for our latest Energy Source video animation, which takes a look at enhanced geothermal systems — or “superhot rock energy” — and asks if they could have a role to play in the push to decarbonise.

In Data Drill, Amanda Chu sticks with Opec, reflecting on the group’s latest World Oil Outlook — and how its view of the future differs from that in the International Energy Agency’s World Energy Outlook, released last week.

Thank you for reading. — Derek

Opinion: ‘Mixed messages’ are holding back oil investment
Haitham Al Ghais is secretary-general of Opec

Over the past year and in the run-up to COP27, the discourse around energy, climate and sustainable development has become increasingly emotive and more forceful. This is warranted, given the energy crisis in Europe, the pressing need to reduce global emissions, and the scourge of energy poverty that has been worsened by the pandemic. The challenges before us are enormous.

But the discourse needs to be inclusive, welcoming all voices to the table. We cannot return to a world that is limited by the question: are you for or against fossil fuels? It cannot be just one or the other. This limits the options available to help the world meet the interwoven challenges of energy affordability and security that have emerged starkly in the past year, while also reducing greenhouse gas emissions.

Expanding populations and growing economies mean the world will need more energy — we calculate 23 per cent more energy by 2045. Meeting this extra demand, while also lowering global emissions in line with the Paris agreement, calls for a broad energy mix and unprecedented collaboration.

Investment will be key to providing the energy needed. For example, we calculate that the oil industry alone must spend more than $12tn between now and 2045, or more than $500bn per year. But spending on energy has been down in recent years: a legacy of industry downturns, the pandemic, and markets’ growing focus on environmental, social, and governance issues. The shortfall now threatens the very sustainability of the global energy system.

This is a problem all stakeholders must work together to address, creating a long-term investment-friendly climate that makes sufficient finance available. It must be an investment environment that works for both producers and consumers, developed and developing countries.

We have heard calls for oil and gas producing countries to ensure stable and sustainable global energy supplies. But we have also heard industrialised countries pledge to end financing in fossil fuel projects.

These mixed messages will do little to spur the investment needed in an oil industry that is characterised by high upfront costs that might pay off only over decades. We need clear signals of oil’s continuing importance to the world’s long-term energy future.

The chronic under-investment we have seen in the oil industry has resulted in shrinking spare capacity, constraints on production, and reduced refinery output — all at a time when demand for crude and oil products continues to rise.

Bear in mind, too, that global oil production declines at an average rate of about 5 per cent a year. In today’s 100mn barrels-a-day market, that’s 5mn more barrels a day that must be produced just to hold output steady each year. It requires huge investment — and that’s before we think about how much more oil the world might need next year, and beyond.

We need a holistic view of this investment challenge, one that accepts all forms of energy to enable an orderly, inclusive and just energy transition. If the world does not get it right, it could sow the seeds of future energy crises.

Opec members are ready, willing and able to play a central role.

We are investing in long-term oil capacity, in both the upstream and downstream. We are mobilising cleaner technologies and our expertise to help the industry reduce its carbon footprint as we make major investments in everything from renewables to new hydrogen capacity.

History shows that energy transitions can take many decades and follow different paths. Furthermore, the developed and developing world have vastly different capabilities, economic drivers, and above all needs — such as the 700mn people who lack access to electricity and the 2.4bn still using inefficient and polluting systems.

Today’s market turmoil shows what happens when we ignore the complexity of our global energy system and seek solutions that are too narrow. We need to work with each other, not against each other. The investment the world needs must focus on an “all-peoples, all-fuels and all-technologies” approach. This will be vital in finding a sustainable future that leaves no one behind. (Haitham Al Ghais)

Data Drill
Opec raised its long-term oil demand forecast yesterday in a report that struck a bullish tone compared with other projections for the market.

In its annual outlook, the oil cartel said demand would rise by 13mn barrels a day compared with 2021, reaching 110mn b/d in 2045 — an upward revision of 1.6mn b/d from last year’s forecast.

Oil will remain the main energy source in 2045, making up about 29 per cent of the global energy mix, says Opec. Natural gas will be the second-largest source, rising from 66.4mn barrels of oil equivalent per day to 85.3mn boe/d in 2045. Only coal use will decline over the next decade, according to Opec’s outlook.

Developing countries led by China and India will drive the growth in oil and natural gas demand. While oil consumption in the group of richer western countries that make up the OECD is expected to fall nearly 11mn b/d by 2045, non-OECD demand is expected to grow 24mn b/d.

Opec’s outlook clashes with other big forecasters that paint a less optimistic picture of the future of oil demand. A host of Wall Street banks, think-tanks and western oil companies have said consumption could peak this decade.

The International Energy Agency last week said for the first time that peak demand could be on the horizon. Under prevailing policies, its modelling found, oil demand “levels off in the mid-2030s before ebbing slightly to mid-century”.

The IEA expects energy-related emissions to peak in the mid-2020s and fall below 2021 levels by the end of the decade. Opec does not expect peak emissions until after 2030.

>>> Pfizer beats by $0.38, beats on revs; raises FY22 guidance (46.55)

Pfizer beats by $0.38, beats on revs; raises FY22 guidance
  • Reports Q3 (Sep) earnings of $1.78 per share, excluding non-recurring items, $0.38 better than the S&P Capital IQ Consensus of $1.40; revenues fell 6.0% year/year to $22.64 bln vs the $21.1 bln S&P Capital IQ Consensus.
  • Co issues raised guidance for FY22, sees EPS of $6.40-6.50 from $6.30-6.45 vs. $6.39 S&P Capital IQ Consensus; sees FY22 revs of $99.5-102.0 bln from $98-102 bln vs. $99.64 bln S&P Capital IQ Consensus. Guidance Details: Comirnaty revenues of approximately $34 billion, which reflects favorable operational updates compared to prior guidance, partially offset by unfavorable incremental impacts from foreign exchange. This guidance includes doses expected to be delivered in fiscal 2022(5), primarily under contracts signed as of mid-October 2022.
  • Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: "I continue to be proud of our colleagues' excellence, ingenuity and unwavering commitment to bringing breakthroughs to patients. Over the next 18 months, we expect to have up to 19 new products or indications in the market -- including the five for which we have already begun co-promotion or commercialization earlier this year. Many of these 19 programs are already largely de-risked from a clinical perspective, the majority were discovered in-house, and nearly all would be for indications outside of COVID-19. This quarter, we set the stage for these potential launches by reorganizing our commercial operations to better capitalize on these opportunities. We also reported positive pivotal data for several of these exciting pipeline programs, including our RSV vaccine candidate for older adults and for infants through maternal vaccination, Prevnar 20 for children, the potential combination treatment of Talzenna and Xtandi in men with metastatic castration-resistant prostate cancer, and our pentavalent meningococcal vaccine candidate for adolescents and young adults. If approved, we expect each of these to be key contributors to our growth aspirations through 2025 and beyond."

>>> US Insider Trading: notable purchases

Insider Trading: notable purchases -- CEO adds to ALLE; notable sales -- EVP active in KBH

Buyers:
  • ALLE President and CEO bought 12,500 shares at $103.69 - $104.87 worth ~$1.3 mln.
  • BDTX 10% owner bought 364,652 shares at $1.8741 - $2.1793 worth ~$736K.
Sellers:
  • CBZ Director sold 20,000 shares at $50.15 worth ~$1.0 mln.
  • FCFS Director sold 8,000 shares at $96.00 worth ~$768K.
  • KBH EVP, Real Estate & Bus. Dev. sold 29,777 shares at $28.66 - $28.91 worth ~$857K.
  • MOH Director sold 3,000 shares at $354.35 - $355.65 worth ~$1.06 mln.
  • MSCI Chief Human Resources Officer sold 7,500 shares at $452.88 - $461.66 worth ~$3.45 mln.

WSJ : Victoria’s Secret to Buy Lingerie Brand Adore Me for $400 Million

Victoria’s Secret to Buy Lingerie Brand Adore Me for $400 Million
Retailer to acquire online rival that has focused on inclusive marketing

Victoria’s Secret VSCO -2.54% & Co. is buying online lingerie seller AdoreMe Inc., adding a brand known for inclusive sizing and body positivity as the retailer tries to move away from a legacy built largely on sex appeal.

Victoria’s Secret is paying $400 million in cash for Adore Me, a direct-to-consumer business that started about a decade ago. The online lingerie seller is on track for about $240 million in revenue this year, according to Victoria’s Secret. It comes after Victoria’s Secret itself has shifted its marketing, hiring more diverse models, and discussed plans to add new brands to its mix.

The New York-based startup has more than 1.2 million customers, mostly bargain seekers, who purchase its products online through monthly subscriptions and one-time buys. Customers can also try on Adore Me’s apparel at home before purchasing.

Chief Executive Martin Waters said Victoria’s Secret plans to use those online shopping features with its other brands. “They’re significantly further advanced in the way that they use technology at the forefront of everything that they do,” Mr. Waters said. He expects the deal will also bring in more cost-conscious consumers.

Victoria’s Secret plans to finance the deal with cash on hand. The deal includes further cash consideration, a portion of which is fixed and the other is based on performance goals over a two-year period. The deal is expected to close by the end of January, pending regulatory approval.

Adore Me founder and Chief Executive Morgan Hermand-Waiche will continue to lead the business following the acquisition, Victoria’s Secret said. Adore Me has 560 employees, all of which will continue to work for the brand, Mr. Waters said.

Last year, Victoria’s Secret logged $6.79 billion in sales, up 25% from the year prior. The retailer expects full-year sales to decline as consumers face persistent inflation, among other macroeconomic challenges.

Reynoldsburg, Ohio-based Victoria’s Secret recently outlined a long-term plan to grow market share and be more inclusive to its customer base. The retailer has attempted to change its messaging since splitting off from L Brands last year.

“We’re on our own journey to become significantly more diverse and more inclusive in the way that we go to market, and I feel good about where we are on that journey,” Mr. Waters said.

Victoria’s Secret became a stand-alone public company last year after a failed deal to sell a controlling stake to a private-equity firm. Mr. Waters became CEO of the lingerie seller in November 2020 and sought to lead its turnaround.

The company has since swapped out its Victoria’s Secret Angels for a group called the VS Collective, which features famous women such as soccer star Megan Rapinoe and Indian actress Priyanka Chopra Jonas. It has also added in its stores images of natural-looking women and mannequins with different body types. Maternity apparel and shapewear have hit the shelves, along with a perfume meant to enhance a person’s natural smell.